Jill Pearcy

Director, Reputation Association of the British Pharmaceutical Industry (ABPI)

Jill Pearcy joined the ABPI in 2018 and drives work on the reputation of the research-based pharmaceutical industry in the UK as well as leading on areas including equity, diversity and inclusion and reputation monitoring. Jill has also led projects within the ABPI to develop and evolve the ABPI Code of Practice. Jill has an extensive background in communications and engagement, with a focus on highly-regulated industries at the interface of public and private sectors. She was previously Head of Corporate Communications at HS2 Ltd, the infrastructure megaproject to build the UK’s high-speed rail network. Earlier in her career, Jill led media relations at NATS, the UK’s air traffic controllers, and before that headed up communications for US technology companies in Europe. She has an MSc in Corporate Governance and Business Ethics.

Day 1 - June 26th

4:00 PM Panel Discussion: Educating Patients and Building Trust on Social Media

Reaching your customers on the platforms that they engage with the most is one of the major benefits of social media marketing. According to a Forbes survey, 1 in 10 Americans get their health information on social media. As digitally native generations get older, this trend is sure to increase. This makes social media an avenue that brands should be exploring to educate and build trust with their target audience. This conversation will highlight the benefits of pharma marketing on social media while exploring ways that marketers can:

- Handle internal objections for pursuing social media strategies.

- Build trust on different platforms and enhance KOL development.

- Work with patient advocacy teams to identify real patients who can champion your brand and help educate others.

Day 2 - June 27th

11:40 AM Panel Discussion with Live Polling | The Importance of Equitable Access for Sustained Brand Success

Ensuring equitable access to medication is a key moral and commercial imperative for leaders, and learning how to communicate with a wider patient base is at the top of proficiencies that teams are investing in. Join us for a panel that will tie together the worlds of market access and patient marketing to showcase just how and why it is so important to ensure that access to medication, and the way we share and educate patients on it, is meaningful and equitable.

Check out the incredible speaker line-up to see who will be joining Jill.

Download The Latest Agenda